Physician profile
Jennifer Black
NPI 1427809656
$579.75
in general payments reported to CMS, 2019-2025
13 companies · $463 in 2025
The $463 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $117 · 2025: $463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $580.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $579.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $134.39 | 2025 | Erleada |
| Pfizer INC. | $73.98 | 2024 | |
| Immunitybio, INC. | $73.15 | 2025 | |
| Inari Medical, INC. | $62.14 | 2024-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Endo USA, INC. | $45.95 | 2025 | Xiaflex, Aveed |
| Tolmar, INC. | $42.49 | 2025 | Jatenzo, Eligard |
| Progenics Pharmaceuticals, INC. | $34.43 | 2025 | |
| Sumitomo Pharma America, INC. | $20.87 | 2025 | Gemtesa |
| Stryker Corporation | $20.28 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Ferring Pharmaceuticals INC. | $19.88 | 2025 | Adstiladrin |
| Astrazeneca Pharmaceuticals LP | $19.71 | 2025 | Imfinzi |
| Coloplast Corp | $18.97 | 2025 | |
| Teleflex LLC | $13.51 | 2025 | Urolift |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Black listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.